The DOI matches its Crossref record; 193 of the 193 references it cites were found in a registry or an index.
Foundations of gastrointestinal-based drug delivery and future developments
Open accessAbstract
Gastrointestinal-based drug delivery is considered the preferred mode of drug administration owing to its convenience for patients, which improves adherence. However, unique characteristics of the gastrointestinal tract (such as the digestive environment and constraints on transport across the gastrointestinal mucosa) limit the absorption of drugs. As a result, many medications, in particular biologics, still exist only or predominantly in injectable form. In this Review, we examine the fundamentals of gastrointestinal drug delivery to inform clinicians and pharmaceutical scientists. We discuss general principles, including the challenges that need to be overcome for successful drug formulation, and describe the unique features to consider for each gastrointestinal compartment when designing drug formulations for topical and systemic applications. We then discuss emerging technologies that seek to address remaining obstacles to successful gastrointestinal-based drug delivery. In this Review, Chu and Traverso provide an overview of gastrointestinal-based drug delivery, discussing conventional delivery methods and challenges posed by the gastrointestinal tract as a drug delivery environment, as well as emerging technologies. Unique characteristics of the gastrointestinal tract must be taken into account when designing drugs for oral or rectal administration. Physical boundary conditions include swallowing constraints, lumen size, drug residence and transit times, mucin and epithelial turnover, and wall thickness of the gastrointestinal tract. Differences in boundary conditions between anatomical compartments, as well as variation in absorptive area, pH, cells and transporters, permeability, and bacterial population, are both a challenge and an opportunity for targeted drug delivery. Strategies to enable gastrointestinal delivery of biologics include non-physical technologies that stabilize the drug and/or enhance absorption, and physical technologies that use a device for mucosal penetration. Strategies to achieve ultra-long (>24 h) systemic drug delivery include gastrointestinal resident systems and implants. Additional emerging technologies in gastrointestinal drug delivery include high-throughput systems for drug development, electronics and closed-loop systems, novel triggers, microorganism-based and cell-based therapeutics, and new technologies to maximize the endoscope. Unique characteristics of the gastrointestinal tract must be taken into account when designing drugs for oral or rectal administration. Physical boundary conditions include swallowing constraints, lumen size, drug residence and transit times, mucin and epithelial turnover, and wall thickness of the gastrointestinal tract. Differences in boundary conditions between anatomical compartments, as well as variation in absorptive area, pH, cells and transporters, permeability, and bacterial population, are both a challenge and an opportunity for targeted drug delivery. Strategies to enable gastrointestinal delivery of biologics include non-physical technologies that stabilize the drug and/or enhance absorption, and physical technologies that use a device for mucosal penetration. Strategies to achieve ultra-long (>24 h) systemic drug delivery include gastrointestinal resident systems and implants. Additional emerging technologies in gastrointestinal drug delivery include high-throughput systems for drug development, electronics and closed-loop systems, novel triggers, microorganism-based and cell-based therapeutics, and new technologies to maximize the endoscope.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Molecular targeting of FATP4 transporter for oral delivery of therapeutic peptide
Hu, Z., Nizzero, S., Goel, S., Hinkle, L. E., Wu, X., Li, C., Mauro Ferrari, B., & Shen, H. (2020) · Science Advances · doi:10.1126/sciadv.aba0145 · Cited by 19
RetractedOsterberg, L., & Blaschke, T. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050100 · Cited by 7,974
Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange, D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J., et al. (2009) · Nature · doi:10.1038/nature07935 · Cited by 7,204
Identification of stem cells in small intestine and colon by marker gene Lgr5
Barker, N., van Es, J. H., Kuipers, J., Kujala, P., van den Born, M., Cozijnsen, M., Haegebarth, A., Korving, J., Begthel, H., Peters, P. J., et al. (2007) · Nature · doi:10.1038/nature06196 · Cited by 5,687
Amidon, G. L., Lennernäs, H., Shah, V. P., & Crison, J. R. (1995) · Pharmaceutical Research · doi:10.1023/a:1016212804288 · Cited by 5,430
Reconstituting organ-level lung functions on a chip
Huh, D., Matthews, B. D., Mammoto, A., Montoya-Zavala, M., Hsin, H. Y., & Ingber, D. E. (2010) · Science · doi:10.1126/science.1188302 · Cited by 4,250
Kirk, J., MacDonald, A., Lavender, P., Dean, J., & Rubin, G. (2017) · Biomedicine Hub · doi:10.1159/000480347 · Cited by 3,887
Sato, T., Stange, D. E., Ferrante, M., Vries, R. G. J., van Es, J. H., van den Brink, S., van Houdt, W. J., Pronk, A., van Gorp, J., Siersema, P. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.050 · Cited by 3,753
Organoid Models and Applications in Biomedical Research
Xinaris, C., Brizi, V., & Remuzzi, G. (2015) · Nephron · doi:10.1159/000433566 · Cited by 3,515
Impact of Nanotechnology on Drug Delivery
Farokhzad, O. C., & Langer, R. (2009) · ACS Nano · doi:10.1021/nn900002m · Cited by 3,348
Cited by
Novel nano-encapsulated probiotic agents: Encapsulate materials, delivery, and encapsulation systems
Xu, C., Ban, Q., Wang, W., Hou, J., & Jiang, Z. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2022.06.061 · Cited by 225
Li, B., Zu, M., Jiang, A., Cao, Y., Wu, J., Shahbazi, M.-A., Shi, X., Reis, R. L., Kundu, S. C., & Xiao, B. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122530 · Cited by 67
Metadata
- Authors
- Chu, J. N., & Traverso, G.
- Venue
- Nature Reviews Gastroenterology & Hepatology
- Published
- 2021-11-16
- Volume
- 19
- Issue
- 4
- Pages
- 219-238
- ISSN
- 1759-5045 (ISSN-L)
- 1759-5053
- OpenAlex
- W3213425375
- Cited by
- 289
- References
- 193
- FWCI
- 3.58
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Foundations of gastrointestinal-based drug delivery and future developments. https://app.cochat.ai/papers/10.1038/s41575-021-00539-w
- The paper
- Chu, J. N., & Traverso, G. (2022). Foundations of gastrointestinal-based drug delivery and future developments. Nature Reviews Gastroenterology & Hepatology. https://doi.org/10.1038/s41575-021-00539-w
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.